IRTC on Nasdaq
iRhythm Holdings, Inc.
Surgical and medical instruments and apparatus company, listed on Nasdaq (IRTC).
Price unavailable
Last updated Oct 18, 2026.
Overview
Compare with Alphatec Holdings, Inc., Orthofix Medical Inc. or Novocure (Jersey), or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
70.6%Gross margin3
-7.7%Operating margin3
-6.0%Net margin3
26.2%Revenue growth, 20253
-29.2%Return on equity3
$34.5MFree cash flow3
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Commercial Payors brought in 52% of the revenue iRhythm Holdings, Inc. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Commercial Payors | $267.2M | $311.6M | $392.2M |
| Centers For Medicare And Medicaid | $122.4M | $142.4M | $179.3M |
| Healthcare Institutions | $71.0M | $95.1M | $125.6M |
| Non-contracted Third-party Payors | $32.1M | $42.7M | $49.9M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue29¢$219.9M
- Selling, general and admin66¢$492.6M
- Other costs5¢$33.7M
- Income tax0¢$953.0K
Out of $747.1M in revenue.3 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Capital spending57¢$46.3M
- Kept or used elsewhere43¢$34.5M
Out of $80.9M of cash from operations.3
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue, net | $747.1M | $591.8M | $492.7M |
| Cost of revenue | $219.9M | $184.3M | $160.9M |
| Gross profit | $527.2M | $407.5M | $331.8M |
| Research and development | $84.6M | $71.5M | $60.2M |
| Acquired in-process research and development | $3.0M | $32.4M | $0 |
| Selling, general and administrative | $492.6M | $418.6M | $385.6M |
| Impairment charges | $4.5M | $641.0K | $11.1M |
| Total operating expenses | $584.7M | $523.0M | $457.0M |
| Loss from operations | -$57.4M | -$115.5M | -$125.2M |
| Interest income | $21.5M | $21.9M | $6.4M |
| Interest expense | -$13.2M | -$12.8M | -$3.6M |
| Loss on extinguishment of debt | $0 | -$7.6M | $0 |
| Other income (expense), net | $5.4M | $1.3M | -$198.0K |
| Total interest and other income (expense), net | $13.8M | $2.8M | $2.5M |
| Loss before income taxes | -$43.6M | -$112.7M | -$122.7M |
| Income tax provision | $953.0K | $565.0K | $750.0K |
| Net loss | -$44.6M | -$113.3M | -$123.4M |
| Net loss per common share, basic (in USD per share) | -$1.39 | -$3.63 | -$4.04 |
| Net loss per common share, diluted (in USD per share) | -$1.39 | -$3.63 | -$4.04 |
| Weighted-average shares, basic (in shares) | 32.0M shares | 31.2M shares | 30.5M shares |
| Weighted-average shares, diluted (in shares) | 32.0M shares | 31.2M shares | 30.5M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 5 fiscal years (annual) or 5 quarters (quarterly), latest first.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-07-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Cash and cash equivalents | $236.0M | $419.6M | $36.2M | ||
| Marketable securities | $347.8M | $116.0M | |||
| Accounts receivable, net | $75.7M | $79.9M | |||
| Inventory | $21.6M | $14.0M | |||
| Prepaid expenses and other current assets | $21.7M | $16.3M | |||
| Total current assets | $702.8M | $645.8M | |||
| Property and equipment, net | $151.6M | $125.1M | |||
| Operating lease right-of-use assets | $41.8M | $47.6M | $4.0M | ||
| Restricted cash | $8.4M | $8.4M | $0 | ||
| Goodwill | $862.0K | $862.0K | |||
| Long-term strategic investments | $69.9M | $61.9M | |||
| Other assets | $44.7M | $41.9M | |||
| Total assets | $1.0B | $931.4M | |||
| Accounts payable | $2.3M | $7.2M | |||
| Accrued liabilities | $128.7M | $84.9M | |||
| Deferred revenue | $4.2M | $2.9M | |||
| Operating lease liabilities, current portion | $16.7M | $15.9M | |||
| Total current liabilities | $151.9M | $110.9M | |||
| Long-term senior convertible notes | $649.5M | $646.4M | |||
| Other noncurrent liabilities | $908.0K | $8.6M | |||
| Operating lease liabilities, noncurrent portion | $65.0M | $74.6M | $4.0M | ||
| Total liabilities | $867.3M | $840.5M | |||
| Preferred stock, $0.001 par value 5,000 shares authorized; none issued and outstanding at December 31, 2025 and 2024 | $0 | $0 | |||
| Common stock, $0.001 par value 100,000 shares authorized; 32,526 shares issued and 32,297 shares outstanding at December 31, 2025, respectively; and 31,621 shares issued and 31,392 shares outstanding at December 31, 2024, respectively | $32.0K | $31.0K | |||
| Additional paid-in capital | $980.8M | $874.6M | |||
| Accumulated other comprehensive income | $403.0K | $165.0K | |||
| Accumulated deficit | -$803.4M | -$758.9M | |||
| Treasury stock, at cost; 229252 shares at December 31, 2025 and 2024, respectively | -$25.0M | -$25.0M | |||
| Total stockholders equity | $152.7M | $90.9M | $210.1M | $239.8M | |
| Total liabilities and stockholders equity | $1.0B | $931.4M | |||
| Preferred stock, par value (in USD per share) | $0.00 | $0.00 | |||
| Preferred stock, shares authorized (in shares) | 5.0M shares | 5.0M shares | |||
| Preferred stock, shares issued (in shares) | 0 shares | 0 shares | |||
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | |||
| Common stock, par value (in USD per share) | $0.00 | $0.00 | |||
| Common stock, shares authorized (in shares) | 100.0M shares | 100.0M shares | |||
| Common stock, shares issued (in shares) | 32.5M shares | 31.6M shares | |||
| Common stock, shares outstanding (in shares) | 32.3M shares | 31.4M shares | |||
| Treasury stock (in shares) | 229.0K shares | 229.0K shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-07-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Cash and cash equivalents | $236.0M | $419.6M | $36.2M | ||
| Marketable securities | $347.8M | $116.0M | |||
| Accounts receivable, net | $75.7M | $79.9M | |||
| Inventory | $21.6M | $14.0M | |||
| Prepaid expenses and other current assets | $21.7M | $16.3M | |||
| Total current assets | $702.8M | $645.8M | |||
| Property and equipment, net | $151.6M | $125.1M | |||
| Operating lease right-of-use assets | $41.8M | $47.6M | $4.0M | ||
| Restricted cash | $8.4M | $8.4M | $0 | ||
| Goodwill | $862.0K | $862.0K | |||
| Long-term strategic investments | $69.9M | $61.9M | |||
| Other assets | $44.7M | $41.9M | |||
| Total assets | $1.0B | $931.4M | |||
| Accounts payable | $2.3M | $7.2M | |||
| Accrued liabilities | $128.7M | $84.9M | |||
| Deferred revenue | $4.2M | $2.9M | |||
| Operating lease liabilities, current portion | $16.7M | $15.9M | |||
| Total current liabilities | $151.9M | $110.9M | |||
| Long-term senior convertible notes | $649.5M | $646.4M | |||
| Other noncurrent liabilities | $908.0K | $8.6M | |||
| Operating lease liabilities, noncurrent portion | $65.0M | $74.6M | $4.0M | ||
| Total liabilities | $867.3M | $840.5M | |||
| Preferred stock, $0.001 par value 5,000 shares authorized; none issued and outstanding at December 31, 2025 and 2024 | $0 | $0 | |||
| Common stock, $0.001 par value 100,000 shares authorized; 32,526 shares issued and 32,297 shares outstanding at December 31, 2025, respectively; and 31,621 shares issued and 31,392 shares outstanding at December 31, 2024, respectively | $32.0K | $31.0K | |||
| Additional paid-in capital | $980.8M | $874.6M | |||
| Accumulated other comprehensive income | $403.0K | $165.0K | |||
| Accumulated deficit | -$803.4M | -$758.9M | |||
| Treasury stock, at cost; 229252 shares at December 31, 2025 and 2024, respectively | -$25.0M | -$25.0M | |||
| Total stockholders equity | $152.7M | $90.9M | $210.1M | $239.8M | |
| Total liabilities and stockholders equity | $1.0B | $931.4M | |||
| Preferred stock, par value (in USD per share) | $0.00 | $0.00 | |||
| Preferred stock, shares authorized (in shares) | 5.0M shares | 5.0M shares | |||
| Preferred stock, shares issued (in shares) | 0 shares | 0 shares | |||
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | |||
| Common stock, par value (in USD per share) | $0.00 | $0.00 | |||
| Common stock, shares authorized (in shares) | 100.0M shares | 100.0M shares | |||
| Common stock, shares issued (in shares) | 32.5M shares | 31.6M shares | |||
| Common stock, shares outstanding (in shares) | 32.3M shares | 31.4M shares | |||
| Treasury stock (in shares) | 229.0K shares | 229.0K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net loss | -$44.6M | -$113.3M | -$123.4M |
| Depreciation and amortization | $20.7M | $20.7M | $16.3M |
| Stock-based compensation | $88.3M | $76.0M | $77.2M |
| Amortization of premium and accretion of discounts, net | -$3.1M | -$1.4M | -$5.0M |
| Amortization of operating lease right-of-use assets | $5.7M | $5.1M | $5.8M |
| Amortization of debt discount | $3.1M | $2.8M | $15.0K |
| Change in fair value of strategic investments | -$5.7M | -$1.9M | $0 |
| Provision for credit losses and contractual allowances | $99.7M | $73.5M | $69.6M |
| Acquired in-process research and development | $3.0M | $32.4M | $0 |
| Loss on extinguishment of debt | $0 | $7.6M | $0 |
| Impairment charges | $4.5M | $641.0K | $11.1M |
| Other | $967.0K | $432.0K | $322.0K |
| Accounts receivable | -$95.4M | -$91.9M | -$81.2M |
| Inventory | -$8.5M | -$224.0K | $979.0K |
| Prepaid expenses and other current assets | -$5.4M | $5.3M | -$11.0M |
| Other assets | -$2.9M | $3.2M | -$22.8M |
| Accounts payable and accrued liabilities | $28.0M | -$7.4M | $17.3M |
| Deferred revenue | $1.3M | -$374.0K | $255.0K |
| Operating lease liabilities | -$8.8M | -$7.7M | -$5.6M |
| Net cash provided by (used in) operating activities | $80.9M | $3.4M | -$50.1M |
| Purchases of property and equipment | -$46.3M | -$33.9M | -$40.4M |
| Purchases of marketable securities | -$466.1M | -$118.2M | -$164.3M |
| Maturities of marketable securities | $237.7M | $101.2M | $206.5M |
| Purchases of strategic investments | -$2.3M | -$57.0M | -$3.0M |
| Purchase of acquired in-process research and development | $0 | -$15.0M | $0 |
| Net cash used in investing activities | -$277.1M | -$123.0M | -$1.2M |
| Proceeds from issuance of 2029 notes | $0 | $661.2M | $0 |
| Purchases of capped call transactions | $0 | -$72.4M | $0 |
| Purchase of treasury stock | $0 | -$25.0M | $0 |
| Proceeds from issuance of common stock in connection with employee equity incentive plans | $12.6M | $8.5M | $8.8M |
| Net cash provided by financing activities | $12.6M | $511.4M | $8.8M |
| Effect of exchange rate changes | $1.0K | -$6.0K | -$169.0K |
| Net increase (decrease) in cash and cash equivalents | -$183.6M | $391.8M | -$42.7M |
| Interest paid | $9.9M | $6.4M | $3.0M |
| Cash taxes paid | $1.2M | $923.0K | $1.1M |
| Cash paid for operating lease liabilities | $15.9M | $15.2M | $14.1M |
| Cash received from tenant improvement allowances | $745.0K | $736.0K | $1.6M |
| Property and equipment costs included in accounts payable and accrued liabilities | $407.0K | $275.0K | $1.9M |
| Right-of-use assets obtained in exchange for operating lease liabilities | $0 | $4.0M | $4.4M |
| Capitalized stock-based compensation in property and equipment | $5.3M | $6.8M | $7.4M |
No quarter-by-quarter statement was filed.
Leadership
Who has led iRhythm Holdings, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
20202025
- Chief executive officerMichael J. Coyle Jan 15, 2021 to Feb 26, 202111
- Chief executive officerDouglas Devine Jul 7, 2021 to Jul 7, 202112
- Chief executive officerQuentin S. Blackford Oct 5, 2021 to now13
- Chief executive officerKevin M. King Oct 19, 2016 to Nov 16, 202014
- PresidentMichael J. Coyle Jan 15, 2021 to Feb 26, 202111
- PresidentQuentin S. Blackford Oct 5, 2021 to now13
- PresidentKevin M. King Oct 19, 2016 to Nov 16, 202014
- Chief financial officerDaniel G. Wilson Dec 27, 2024 to now15
- Chief financial officerBrice Bobzien Aug 10, 2022 to Aug 12, 202416
- Chief financial officerDouglas Devine Jun 22, 2020 to Jul 11, 202217
- Chief financial officerMatthew C. Garrett Oct 19, 2016 to Mar 3, 202018
- Chief operating officerDouglas Devine Feb 17, 2022 to Mar 7, 202319
- Chief operating officerKarim Karti Jul 26, 2018 to Apr 27, 202020
Board members and other officers (31)
- EVP, CHIEF PEOPLE OFFICERJulianne Rodda Apr 6, 2026 to now21
- Chief Technology OfficerBrian Lee Lawrence Apr 21, 2025 to now22
- EVP, Strategy & Corp DevtSean Clinton Freeman Jul 1, 2025 to now23
- EVP Strategic Business OpsMervin Smith Aug 18, 2023 to now24
- EVP, CMO & CSOMinang Turakhia Jun 8, 2022 to now25
- EVP, Chief Risk OfficerSumi Shrishrimal Jun 14, 2022 to now26
- Chief Commercial OfficerChad Patterson Jul 27, 2022 to now27
- EVP, Chief HR OfficerReyna M. Fernandez Jul 27, 2022 to Mar 1, 202328
- EVP, Strategy Corp Dev Inv RelDaniel G. Wilson May 10, 2021 to Feb 14, 202529
- EVP, Research & DevelopmentMark J. Day Mar 27, 2019 to Mar 5, 202430
- EVP, SalesDavid A. Vort Oct 19, 2016 to Mar 8, 202231
- OfficerDerrick Sung Oct 19, 2016 to Mar 18, 201932
- Board memberJason H. Patten Mar 19, 2026 to now33
- Board memberKaren K. McGinnis Jul 8, 2025 to now34
- Board memberKevin C. Oboyle Jul 8, 2025 to now35
- Board memberBrian B. Yoor Jun 5, 2023 to now36
- Board memberMojdeh Poul Jun 5, 2023 to Jun 3, 202437
- Board memberMichael J. Coyle Jan 15, 2021 to Feb 26, 202111
- Board memberQuentin S. Blackford Oct 5, 2021 to now13
- Board memberKaren Ling Nov 1, 2021 to now38
- Board memberRenee Varni Budig May 4, 2020 to May 31, 202239
- Board memberMerz Cathleen Noel Bairey Apr 26, 2018 to now40
- Board memberBruce G. Bodaken Jul 19, 2017 to now41
- Board memberRalph Snyderman Jul 19, 2017 to now42
- Board memberAbhi Talwalkar Oct 19, 2016 to now43
- Board memberClercq Casper L. De Oct 19, 2016 to May 12, 201744
- Board memberKevin M. King Oct 19, 2016 to Mar 8, 202214
- Board memberMark J. Rubash Oct 19, 2016 to now45
- Board memberRaymond W. Scott Oct 19, 2016 to Jun 22, 202146
- Board memberTiba Aynechi Oct 19, 2016 to Apr 11, 201747
- Board memberVijay K. Lathi Oct 19, 2016 to Mar 12, 201848
Former names
Timeline
Filings
421 filings to the SEC since October 2021: 6 annual reports, 15 quarterly reports, 61 major events, 252 insider forms, 35 large holders, 52 other. The latest 20:
- Oct 13, 2026SCHEDULE 13G/A EDGAR
- Oct 5, 20268-K EDGAR
- Sep 22, 20268-K EDGAR
- Sep 3, 20264 EDGAR
- Aug 14, 2026SCHEDULE 13G/A EDGAR
- Aug 13, 20268-K EDGAR
- Aug 13, 2026SCHEDULE 13G EDGAR
- Aug 11, 20264 EDGAR
- Aug 11, 20264 EDGAR
- Aug 11, 20264 EDGAR
- Aug 11, 20264 EDGAR
- Aug 11, 20264 EDGAR
- Aug 6, 202610-Q EDGAR
- Aug 6, 20268-K EDGAR
- Aug 6, 20268-K EDGAR
- Aug 4, 20264 EDGAR
- Aug 4, 20264 EDGAR
- Aug 4, 20264 EDGAR
- Jul 6, 20264 EDGAR
- Jul 6, 20264 EDGAR
The 421 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 35 such filings since October 2021, the latest 10:
- Oct 13, 2026SCHEDULE 13G/A
- Aug 14, 2026SCHEDULE 13G/A
- Aug 13, 2026SCHEDULE 13G
- May 15, 2026SCHEDULE 13G
- May 8, 2026SCHEDULE 13G/A
- Apr 28, 2026SCHEDULE 13G
- Apr 27, 2026SCHEDULE 13G
- Mar 26, 2026SCHEDULE 13G/A
- Mar 23, 2026SCHEDULE 13G
- Feb 13, 2026SCHEDULE 13G/A
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
13F reports cover disclosed long positions in U.S. stocks only.
Members of Congress who traded it
1 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.
| Date | Member | Trade | Amount | Vs S&P since | Filing |
|---|---|---|---|---|---|
| Jun 24, 2019 | Donna Shalala, House | Sale | $1,001 - $15,000 | +122.9% | Report |
Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20SEC EDGARKarim Karti, Chief operating officer
- 21
- 22
- 23
- 24
- 25SEC EDGARMinang Turakhia, EVP, CMO & CSO
- 26
- 27
- 28
- 29
- 30
- 31SEC EDGARDavid A. Vort, EVP, Sales
- 32SEC EDGARDerrick Sung, Officer
- 33SEC EDGARJason H. Patten, Board member
- 34SEC EDGARKaren K. McGinnis, Board member
- 35SEC EDGARKevin C. Oboyle, Board member
- 36SEC EDGARBrian B. Yoor, Board member
- 37SEC EDGARMojdeh Poul, Board member
- 38SEC EDGARKaren Ling, Board member
- 39SEC EDGARRenee Varni Budig, Board member
- 40
- 41SEC EDGARBruce G. Bodaken, Board member
- 42SEC EDGARRalph Snyderman, Board member
- 43SEC EDGARAbhi Talwalkar, Board member
- 44SEC EDGARClercq Casper L. De, Board member
- 45SEC EDGARMark J. Rubash, Board member
- 46SEC EDGARRaymond W. Scott, Board member
- 47SEC EDGARTiba Aynechi, Board member
- 48SEC EDGARVijay K. Lathi, Board member